
Pfizer/BioNTech submit initial data on Covid-19 vaccine for people ages 5 to 11 to FDA, but aren't seeking EUA yet
CNN
Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking emergency use authorization.
A formal submission to request EUA for the vaccine is expected to follow in the coming weeks, the companies said in a statement.
Submissions to the European Medicines Agency and other regulatory authorities are also planned, they said.

The House Judiciary Committee is demanding interviews with four current and former Department of Justice officials who were involved in subpoenaing phone records for several members of Congress around the January 6, 2021, Capitol attack, the day before Republicans interview former special counsel Jack Smith.












